U.S. Global Health Budget Breakdown: HIV, TB, Malaria, Maternal Health & More in 2024

The U.S. Government remains the world’s largest donor to global health, allocating billions annually across targeted programs that address infectious diseases, maternal and child health, nutrition, family planning, and health security. As of fiscal year 2025, the U.S. Global health budget totaled approximately $11.3 billion, distributed across nine key program areas with HIV/AIDS receiving the largest share through PEPFAR, followed by maternal and child health, malaria control via the President’s Malaria Initiative (PMI), tuberculosis, family planning and reproductive health, nutrition, global health security, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and neglected tropical diseases (NTDs). This sustained investment reflects a long-term commitment to reducing global morbidity and mortality, particularly in low- and middle-income countries where health systems face chronic underfunding and workforce shortages.

Key Clinical Takeaways:
• PEPFAR alone accounted for over $4.3 billion in FY2025, supporting antiretroviral therapy for more than 20 million people worldwide and contributing to a 52% decline in AIDS-related deaths since its inception in 2003.
• Investments in malaria control through PMI and the Global Fund have helped avert an estimated 11.7 million malaria deaths between 2000 and 2022, with insecticide-treated net distribution and seasonal malaria chemoprevention driving much of this progress.
• Family planning and reproductive health programs received $607.5 million in FY2025, enabling access to contraceptives for over 27 million women and girls annually, which correlates with reduced maternal mortality and improved birth spacing outcomes in sub-Saharan Africa and South Asia.

The scale of U.S. Global health funding has evolved in response to shifting epidemiological burdens and emerging threats. For instance, while HIV/AIDS once dominated the portfolio, rising concerns about antimicrobial resistance, zoonotic spillover events, and climate-sensitive diseases have elevated the importance of global health security funding, which reached $1.5 billion in FY2025 to support pathogen surveillance, laboratory strengthening, and outbreak response capacity in over 50 countries. This shift mirrors findings from a 2023 World Health Organization report highlighting that 60% of emerging infectious diseases originate in animals, underscoring the need for One Health approaches that integrate human, animal, and environmental surveillance.

“The U.S. Investment in global health security isn’t just charity—it’s epidemiological self-defense. Every dollar spent strengthening lab networks in Uganda or Vietnam reduces the risk that a novel pathogen goes undetected until it’s already spreading globally.”

Similarly, funding for neglected tropical diseases—though representing less than 5% of the total budget—has yielded outsized returns. Programs targeting lymphatic filariasis, schistosomiasis, and soil-transmitted helminths have leveraged mass drug administration campaigns, reaching over 600 million people annually with preventive chemotherapy. According to a 2024 meta-analysis in The Lancet Global Health, these efforts have reduced the prevalence of trachoma by 91% since 2002 and brought four countries to the verge of eliminating lymphatic filariasis as a public health problem. Such successes are often driven by partnerships between USAID, the CDC, and endemic-country ministries of health, with technical support from institutions like the Liverpool School of Tropical Medicine.

Maternal and child health remains a cornerstone of U.S. Global health strategy, with $2.6 billion allocated in FY2025 to improve access to skilled birth attendance, emergency obstetric care, and neonatal resuscitation. These investments align with the United Nations’ Every Woman Every Child initiative and have contributed to a 38% reduction in global maternal mortality between 2000 and 2020. Yet disparities persist: in sub-Saharan Africa, a woman’s lifetime risk of dying from pregnancy-related causes is still 1 in 36, compared to 1 in 4,900 in high-income countries. Addressing this gap requires not only funding but also training and retention of midwives and community health workers—areas where U.S.-supported programs like the Maternal and Child Health Survival Program have demonstrated measurable impact.

“We’ve seen that when community health workers are equipped with ultrasound devices and connected to referral networks via mobile health platforms, facility-based deliveries increase by up to 40% in rural settings. The technology is simple; the challenge is sustaining supply chains and supervision.”

Family planning and reproductive health funding, while politically contentious in some domestic contexts, continues to demonstrate clear public health benefits abroad. Data from the Guttmacher Institute show that every $100 million invested in international family planning prevents approximately 1.8 million unintended pregnancies, 800,000 unsafe abortions, and 7,000 maternal deaths annually. These outcomes are achieved through support for contraceptive supply chains, provider training, and demand-generation campaigns that respect cultural contexts while upholding reproductive autonomy. Organizations such as Pathfinder International and FHI 360, which receive U.S. Funding through USAID, play a critical role in delivering these services at scale.

For healthcare providers, policymakers, and implementers seeking to engage with or learn from these global health initiatives, access to vetted expertise is essential. Clinicians interested in contributing to international medical missions or telehealth collaborations can consult with board-certified infectious disease specialists who have field experience in PEPFAR-supported clinics or PMI-affiliated regions. Similarly, organizations aiming to strengthen supply chain integrity for essential medicines—particularly in the context of global health security or malaria chemoprevention—may benefit from consulting healthcare compliance attorneys who specialize in international regulatory frameworks and FDA/EMA export guidelines. Finally, public health professionals designing community-based interventions for NTDs or maternal health can partner with field-trained epidemiologists to ensure surveillance systems are both culturally appropriate and epidemiologically robust.

The enduring strength of the U.S. Global health budget lies not only in its scale but in its adaptability—shifting resources in response to new evidence, emerging threats, and lessons learned from decades of field implementation. As climate change alters disease vectors and urbanization concentrates populations in informal settlements, the need for agile, data-driven global health financing will only grow. Continued investment in surveillance, health workforce development, and innovative delivery models remains critical to sustaining hard-won gains and preparing for the next generation of health threats.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*